NeuroSense Therapeutics Ltd. Shortterm Employee Benefits Accruals
NeuroSense Therapeutics Ltd. (NRSN) had Shortterm Employee Benefits Accruals of $1.32 million as of 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes
ifrs-full:ShorttermEmployeeBenefitsAccruals · last filed 2024-04-04
- 2023-12-31: Shortterm Employee Benefits Accruals $1.32M.
- 2022-12-31: Shortterm Employee Benefits Accruals $751.00K.
- 2021-12-31: Shortterm Employee Benefits Accruals $115.00K.
- 2020-12-31: Shortterm Employee Benefits Accruals $36.00K.
| Period end | Shortterm Employee Benefits Accruals |
|---|---|
| 2023-12-31 | $1.32M 20-F · filed 2024-04-04 |
| 2022-12-31 | $751.00K 20-F · filed 2024-04-04 |
| 2021-12-31 | $115.00K 20-F · filed 2023-03-22 |
| 2020-12-31 | $36.00K 20-F · filed 2022-04-14 |